Priorities in breast sensation among patients undergoing breast reconstruction
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026-06 · 117 · 210-218
DOI: 10.1016/j.bjps.2026.04.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026-06. Verfasst von Lily Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Mammaplasty, Breast Neoplasms, Sensation, Breast. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Plastic Surgery Foundation.
Abstract (Originalsprache)
PURPOSE Loss of sensation after breast reconstruction can significantly reduce quality of life. Although novel techniques have aimed to restore sensation, patient priorities and the impact on decision-making remain unclear. We explored patient perspectives on the importance of breast sensation in reconstruction. METHODS We conducted a cross-sectional survey of women ≥18 years who underwent breast reconstruction following breast cancer, recruited through online patient communities. Participants provided demographic and cancer-related data, retrospectively ranked sensory modalities, and reported awareness of nerve optimization procedures. Descriptive statistics, t-tests, chi-square tests, and multivariable linear regression were performed. RESULTS Among 235 participants (mean age, 55 years), tactile sensation was recalled as the most important when considering reconstruction (55%), followed by erogenous sensation (35%). After reconstruction, erogenous sensation was the most missed (49%), followed by tactile sensation (38%). Sensation was important for decision-making in 26% of the participants. Over half (54%) were unaware of nerve optimization procedures but would have considered them if informed, whereas only 16% were aware and had considered them. After adjusting for covariates, awareness and consideration of nerve procedures remained independently associated with higher BREAST-Q Satisfaction with Breasts (p = 0.04). Aware participants also reported significantly higher decision confidence, feeling informed, and Satisfaction with Information compared to unaware participants who would have considered these procedures (all p < 0.05). CONCLUSIONS Patient priorities for breast sensation vary and may shift after reconstruction. Awareness and consideration of nerve optimization procedures are independently associated with improved BREAST-Q satisfaction. Structured preoperative counseling, including discussion of sensory outcomes and nerve optimization options, may improve shared decision-making and postoperative satisfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
- Division of Plastic and Reconstructive Surgery, Weill Cornell Medicine, New York, NY, USA.
- Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital, Baltimore, MD, USA. Electronic address: lmundy3@jhmi.edu.
Förderung
- Plastic Surgery Foundation
Zitieren
APA
Zhu, L., Giwa, G. A., Khoo, K. H., Gfrerer, L., Broderick, K. P., & Mundy, L. R. (2026). Priorities in breast sensation among patients undergoing breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery, 117, 210-218. https://doi.org/10.1016/j.bjps.2026.04.017
Vancouver
Zhu L, Giwa GA, Khoo KH, Gfrerer L, Broderick KP, Mundy LR. Priorities in breast sensation among patients undergoing breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;117:210-218. doi:10.1016/j.bjps.2026.04.017
BibTeX
@article{Zhu2026,
author = {Zhu, Lily and Giwa, Ganiat A and Khoo, Kimberly H and Gfrerer, Lisa and Broderick, Kristen P and Mundy, Lily R},
title = {Priorities in breast sensation among patients undergoing breast reconstruction},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
volume = {117},
pages = {210--218},
doi = {10.1016/j.bjps.2026.04.017}
}
EUVIMED